AIG
CLSD

American International Group’s Clearside Biomedical CLSD Stock Holding History

American International Group’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,189
Closed -$25K – 3112
2019
Q1 		$25K Sell
1,189
-38
-3% -$754 ﹤0.01% 2979
2018
Q4 		$20K Sell
1,227
-10
-0.8% -$469 ﹤0.01% 3023
2018
Q3 		$114K Buy
1,237
+23
+2% +$2.73K ﹤0.01% 2762
2018
Q2 		$195K Buy
1,214
+333
+38% +$56.1K ﹤0.01% 2362
2018
Q1 		$142K Sell
881
-48
-5% -$5.85K ﹤0.01% 2469
2017
Q4 		$97K Buy
929
+5
+0.5% +$537 ﹤0.01% 2747
2017
Q3 		$121K Buy
924
+69
+8% +$8.43K ﹤0.01% 2553
2017
Q2 		$117K Buy
855
+454
+113% +$54.5K ﹤0.01% 2626
2017
Q1 		$48K Buy
+401
New +$47.3K ﹤0.01% 2847

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

American International Group's CLSD Position: Q2 2019 in Review

American International Group sold out of Clearside Biomedical (CLSD) in Q2 2019, closing a stake of 1,189 shares — an estimated $25K sold.

American International Group first reported a position in CLSD in Q1 2017 and held it in 9 quarters. The position peaked at $195K in Q2 2018. 50 funds tracked by Wall St. Rank hold CLSD as of Q2 2019.

  • American International Group reported no remaining Clearside Biomedical position as of Q2 2019 after selling out during the quarter.
  • American International Group sold 1,189 Clearside Biomedical shares in Q2 2019, an estimated $25K.
  • American International Group first reported a position in Clearside Biomedical in Q1 2017 and held it in 9 quarters.
  • American International Group's Clearside Biomedical position peaked at $195K in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.